526 related articles for article (PubMed ID: 36736851)
1. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy.
Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y
Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN
Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285
[No Abstract] [Full Text] [Related]
4. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation.
Zhang Y; Swanda RV; Nie L; Liu X; Wang C; Lee H; Lei G; Mao C; Koppula P; Cheng W; Zhang J; Xiao Z; Zhuang L; Fang B; Chen J; Qian SB; Gan B
Nat Commun; 2021 Mar; 12(1):1589. PubMed ID: 33707434
[TBL] [Abstract][Full Text] [Related]
5. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism.
Li D; Zhang M; Chao H
Inflamm Res; 2021 Dec; 70(10-12):1177-1189. PubMed ID: 34537856
[TBL] [Abstract][Full Text] [Related]
6. Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis.
Liu W; Zhou Y; Duan W; Song J; Wei S; Xia S; Wang Y; Du X; Li E; Ren C; Wang W; Zhan Q; Wang Q
Clin Transl Med; 2021 Sep; 11(9):e517. PubMed ID: 34586745
[TBL] [Abstract][Full Text] [Related]
7. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
[TBL] [Abstract][Full Text] [Related]
8. DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma.
Li Q; Yuan H; Zhao G; Ou D; Zhang J; Li L; Li S; Feng T; Gu R; Kou Q; Wang Q; Li S; Wang G; Zhao M; Yu H; Qu J; Lin P; Li K
Biochem Pharmacol; 2024 Jul; 225():116251. PubMed ID: 38701867
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
[TBL] [Abstract][Full Text] [Related]
10. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
[TBL] [Abstract][Full Text] [Related]
11. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
12. PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma.
Li J; Li Y; Wang D; Liao R; Wu Z
J Exp Clin Cancer Res; 2024 May; 43(1):143. PubMed ID: 38745179
[TBL] [Abstract][Full Text] [Related]
13. Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells.
Wang H; Wang C; Li B; Zheng C; Liu G; Liu Z; Zhang L; Xu P
Eur J Med Chem; 2023 Jun; 254():115343. PubMed ID: 37087895
[TBL] [Abstract][Full Text] [Related]
14. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.
Lee J; Roh JL
Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895
[TBL] [Abstract][Full Text] [Related]
15. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity.
Xu C; Sun S; Johnson T; Qi R; Zhang S; Zhang J; Yang K
Cell Rep; 2021 Jun; 35(11):109235. PubMed ID: 34133924
[TBL] [Abstract][Full Text] [Related]
16. Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis.
Chen M; Shi Z; Sun Y; Ning H; Gu X; Zhang L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675129
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation and ferroptosis: The role of GSH and GPx4.
Ursini F; Maiorino M
Free Radic Biol Med; 2020 May; 152():175-185. PubMed ID: 32165281
[TBL] [Abstract][Full Text] [Related]
18. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
[TBL] [Abstract][Full Text] [Related]
19. Role of GPX4 inhibition-mediated ferroptosis in the chemoresistance of ovarian cancer to Taxol in vitro.
Feng Q; Hao S; Fang P; Zhang P; Sheng X
Mol Biol Rep; 2023 Dec; 50(12):10189-10198. PubMed ID: 37924448
[TBL] [Abstract][Full Text] [Related]
20. Ancient dormant virus remnant ERVW-1 drives ferroptosis via degradation of GPX4 and SLC3A2 in schizophrenia.
Zhang D; Wu X; Xue X; Li W; Zhou P; Lv Z; Zhao K; Zhu F
Virol Sin; 2024 Feb; 39(1):31-43. PubMed ID: 37690733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
